SANTIAGO, Chile, Jan. 07, 2022 (GLOBE NEWSWIRE) — You are cordially invited to participate in Banco Santander Chile’s (BSAC) – Get Banco Santander Chile SA Report conference call-webcast on Thursday, February 3, 2022 at 10.00 Read more…
CHICAGO, Jan. 7, 2022 /PRNewswire/ — Palette Software AB has completed a Type 2 SOC 2 examination for the Online Cloud Service Operation for the review period from January 1, 2021, to October 31, 2021. The Read more…
BEIJING, Jan. 7, 2022 /PRNewswire/ — Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. Conventional diagnosis includes imaging or histological evidence of steatosis (accumulated liver fat) in >5% of Read more…
WHEELING, Ill., Jan. 7, 2022 /PRNewswire/ — It is with profound senses of loss and sadness that SG 360° announces the sudden and unexpected death of their President and CEO John A. Wallace, Jr., who Read more…
UK Construction PMI cools off The UK Construction PMI for December indicated that growth at cooled off and fallen to a 3-month low. The PMI slowed to 54.3, down from 55.5 in November. Although the Read more…
PARIS, Ky., Jan. 7, 2022 /PRNewswire/ — A&G Real Estate Partners and Murray Wise Associates LLC are under contract with a stalking horse bidder in the receivership sale of a 1.87 million-square-foot greenhouse and agricultural Read more…
LONDON, Jan. 7, 2022 /PRNewswire/ — Highgate, the fast-growing global CEO and sovereign advisory firm, has kick-started 2022 with two new senior level appointments. APCO UK’s Deputy Managing Director Polly Kennedy joins Highgate as Chief Operating Read more…
LOS ANGELES, Jan. 7, 2022 /PRNewswire/ — Homestead Entertainment unveils new movies the first week of January on Tubi, a Fox Entertainment Company. Beginning Friday, January 7, 2022, new film releases and tv shows broadcast with relevant Read more…
VIRGINIA BEACH, Va., Jan. 07, 2022 (GLOBE NEWSWIRE) — Armada Hoffler Properties, Inc. (AHH) – Get Armada Hoffler Properties, Inc. Report today announced that it has priced an underwritten public offering of 3,500,000 shares of Read more…
Royalty Pharma Extends Capital to Cytokinetics to Support the Commercial Launch of Omecamtiv Mecarbil and the Further Development of Aficamten Royalty Pharma Purchases Royalties on Future Sales of Aficamten Cytokinetics to Host Conference Call and Read more…